By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Immunology are presented in a new report. According to news reporting originating in Toyama, Japan, by NewsRx journalists, research stated, "Here, we developed polymeric microfluidic devices for the isolation of circulating tumor cells. The devices, with more than 30,000 microposts in the channel, were produced successfully by a UV light-curing process lasting 3 min."
The news reporters obtained a quote from the research from Toyama University, "The device surface was coated with anti-epithelial cell adhesion molecule antibody by just contacting the antibody solution, and a flow system including the device was established to send a cell suspension through it. We carried out flow tests for evaluation of the device's ability to capture tumor cells using an esophageal cancer cell line, KYSE220, dispersed in phosphate-buffered saline or mononuclear cell separation from whole blood. After the suspension flowed through the chip, many cells were seen to be captured on the microposts coated with the antibody, whereas there were few cells in the device without the antibody. Owing to the transparency of the device, we could observe the intact and the stained cells captured on the microposts by transmitted light microscopy and phase contrast microscopy, in addition to fluorescent microscopy, which required fluorescence labeling. Cell capture efficiencies (i.e., recovery rates of the flowing cancer cells by capture with the microfluidic device) were measured. The resulting values were 0.88 and 0.95 for cell suspension in phosphate-buffered saline, and 0.85 for the suspension in the mononuclear cell separation, suggesting the sufficiency of this device for the isolation of circulating tumor cells."
According to the news reporters, the research concluded: "Therefore, our device may be useful for research and treatments that rely on investigation of circulating tumor cells in the blood of cancer patients."
For more information on this research see: Polymeric microfluidic devices exhibiting sufficient capture of cancer cell line for isolation of circulating tumor cells. Biomedical Microdevices, 2013;15(4):611-616. Biomedical Microdevices can be contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. (Springer - www.springer.com; Biomedical Microdevices - www.springerlink.com/content/1387-2176/)
Our news correspondents report that additional information may be obtained by contacting T. Ohnaga, Toyama University, Dept. of Immunol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan. Additional authors for this research include Y. Shimada, M. Moriyama, H. Kishi, T. Obata, K. Takata, T. Okumura, T. Nagata, A. Muraguchi and K. Tsukada (see also Immunology).
Keywords for this news article include: Asia, Antibodies, Japan, Toyama, Cancer, Oncology, Immunology, Blood Proteins, Immunoglobulins
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC